Merck & Co., Inc. Treasury Stock 2008-2026 | MRK
Beta
What is treasury stock?
Treasury stock represents shares that were previously issued and later repurchased by the company, reducing total stockholders' equity.
What is Merck & Co., Inc.'s current treasury stock?
Merck & Co., Inc. (MRK) annual treasury stock for 2025 was $63.00B, a 8.05% increase from 2024. Merck & Co., Inc. treasury stock for the quarter ending March 31, 2026 was $63.75B.
What was Merck & Co., Inc.'s treasury stock in 2024?
Merck & Co., Inc. annual treasury stock for 2024 was $58.30B, a 1.48% increase from 2023.
What was Merck & Co., Inc.'s treasury stock in 2023?
Merck & Co., Inc. annual treasury stock for 2023 was $57.45B, a 1.70% increase from 2022.
What is Merck & Co., Inc.'s 5-year treasury stock CAGR?
Merck & Co., Inc. treasury stock grew at a compound annual growth rate (CAGR) of 2.10% from FY2020 to FY2025, going from $56.79B to $63.00B over 5 years.
Treasury Stock History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+2.1%
FY2020
$56.79B
→
FY2025
$63.00B
080910111213141516171819202122232425
5 years selected
Treasury Stock History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $63.00B | +8.1% | 10-K |
| FY2024 | $58.30B | +1.5% | 10-K |
| FY2023 | $57.45B | +1.7% | 10-K |
| FY2022 | $56.49B | -1.1% | 10-K |
| FY2021 | $57.11B | +0.6% | 10-K |
| FY2020 | $56.79B | +1.5% | 10-K |
| FY2019 | $55.95B | +9.9% | 10-K |
| FY2018 | $50.93B | +16.3% | 10-K |
| FY2017 | $43.79B | +8.0% | 10-K |
| FY2016 | $40.55B | +5.2% | 10-K |
| FY2015 | $38.53B | +9.3% | 10-K |
| FY2014 | $35.26B | +19.2% | 10-K |
| FY2013 | $29.59B | +19.7% | 10-K |
| FY2012 | $24.72B | +3.9% | 10-K |
| FY2011 | $23.79B | +6.1% | 10-K |
| FY2010 | $22.43B | +6.6% | 10-K |
| FY2009 | $21.04B | -31.5% | 10-K |
| FY2008 | $30.74B | - | 10-K |
Company: Merck & Co., Inc.Ticker: MRKSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →